CARLISLE COS INC (CSL)

US1423391002 - Common Stock

347.1  -2.9 (-0.83%)

After market: 340.17 -6.93 (-2%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to CSL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 364.62. This target is 5.05% above the current price.
CSL was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CSL.
In the previous month the buy percentage consensus was at a similar level.
CSL was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 347.10345.75362.10364.62393.75 - -0.39% 4.32% 5.05% 13.44%
Up and Down Grades
Date Firm Action Rating
2024-01-17 Baird Maintains Outperform -> Outperform
2023-09-26 Jefferies Downgrade Buy -> Hold
2023-09-25 Oppenheimer Reiterate Outperform -> Outperform
2023-08-18 Zelman & Assoc Downgrade Hold -> Sell
2023-07-27 Oppenheimer Reiterate Outperform -> Outperform
2023-07-13 Baird Maintains Outperform -> Outperform
2023-05-01 BMO Capital Maintains Outperform
2023-04-28 Loop Capital Maintains Buy
2023-04-24 Oppenheimer Maintains Outperform
2023-04-14 Baird Maintains Outperform
2023-04-11 Credit Suisse Maintains Outperform
2023-03-21 BMO Capital Maintains Outperform
2023-03-17 Oppenheimer Maintains Outperform
2023-02-08 Wells Fargo Maintains Outperform
2023-02-08 Baird Maintains Outperform
2023-01-18 Baird Maintains Outperform
2022-10-31 Credit Suisse Maintains Outperform
2022-10-14 Credit Suisse Upgrade Neutral -> Outperform
2022-08-31 Oppenheimer Maintains Outperform
2022-06-23 Baird Maintains Outperform
2022-05-09 Credit Suisse Maintains Neutral
2021-12-08 Oppenheimer Maintains Outperform
2021-11-15 Zelman Initiate Buy
2021-10-22 Oppenheimer Maintains Outperform
2021-07-23 Oppenheimer Maintains Outperform
2021-07-14 Oppenheimer Maintains Outperform
2021-06-30 Northcoast Research Upgrade Neutral -> Buy
2021-05-14 Oppenheimer Maintains Outperform
2021-04-12 Longbow Research Downgrade Buy -> Neutral
2021-04-12 Oppenheimer Maintains Outperform